Gland Pharma Limited has informed the Exchange regarding a press release dated April 06, 2024, titled "Gland Pharma receives approval for Eribulin Mesylate Injection".
Gland Pharma Limited has informed the Exchange regarding a press release dated April 06, 2024, titled "Gland Pharma receives approval for Eribulin Mesylate Injection".